Concepedia

Elisabeth Zirm

EZ

Statistics

Publications

3

Citations

74

H-Index

3

Active since

2012

Affiliations

Jena University Hospital(Current)

Elisabeth Zirm is an author at Jena University Hospital specializing in cell signaling, cell death, and immunology.

Top concepts

Publications per year

2012–2013

3

Publications

3

Ponatinib may overcome resistance of <scp>FLT</scp>3‐<scp>ITD</scp> harbouring additional point mutations, notably the previously refractory <scp>F</scp>691I mutation

Elisabeth Zirm, Bärbel Spies‐Weisshart, Florian H. Heidel et al. · British Journal of Haematology · 2012 · 51 citations

The E3 ubiquitin ligase TRAF2 can contribute to TNF-α resistance in FLT3-ITD-positive AML cells

Ulf Schnetzke, Mike Fischer, Bärbel Spies‐Weisshart et al. · Leukemia Research · 2013 · 13 citations

, , +9

The E3 ubiquitin ligase TRAF6 inhibits LPS-induced AKT activation in FLT3-ITD-positive MV4-11 AML cells

Ulf Schnetzke, Mike Fischer, Anne-Kathrin Kuhn et al. · Journal of Cancer Research and Clinical Oncology · 2012 · 10 citations · Full text

, , +9

1–3 of 3